Goldman Sachs Group Inc Protara Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.8 - $5.33 $427,971 - $814,674	-152,847 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.19 - $6.9 $186,266 - $306,739	-44,455 Reduced 22.53%	152,847 $781,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $254,173 - $320,713	41,329 Added 26.5%	197,302 $1.33 Million
Q3 2021 Nov 10, 2021	BUY	$6.38 - $9.3 $995,107 - $1.45 Million	155,973 New	155,973 $1.08 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $26.9M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.